Back
Danaher Corp. 10K Form
Buy
57
DHR
Danaher Corp.
Last Price:
$209.42
Seasonality Move:
7.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-23 | 10Q | DHR/Danaher Corp. Quarterly |
| 2024-02-21 | 10K | DHR/Danaher Corp. Annual |
| 2023-10-24 | 10Q | DHR/Danaher Corp. Quarterly |
| 2023-07-25 | 10Q | DHR/Danaher Corp. Quarterly |
| 2023-04-25 | 10Q | DHR/Danaher Corp. Quarterly |
| 2023-02-22 | 10K | DHR/Danaher Corp. Annual |
Receive DHR News And Ratings
See the #1 stock for the next 7 days that we like better than DHR
DHR Financial Statistics
Sales & Book Value
| Annual Sales: | $24.6B |
|---|---|
| Cash Flow: | $1.7B |
| Price / Cash Flow: | 28.84 |
| Annual Sales: | $74.32 |
| Price / Book: | 2.84 |
Profitability
| EPS (TTM): | 5.04750 |
|---|---|
| Net Income (TTM): | $3.6B |
| Gross Margin: | $14.5B |
| Return on Equity: | 7.02% |
| Return on Assets: | 4.48% |
Danaher Corp. Earnings Forecast
Key Danaher Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for DHR is 59.11%.
-
The Selling, General & Administrative Expenses for DHR have been equal to 33.52% of Gross Profit Margin.
-
The Research & Development expenses have been 6.50% of Revenue.
-
The Interest Expense is 7.36% of Operating Income.
-
The Net Earning history of DHR is 14.65% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 29 years.
Danaher Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | DHR |
| CUSIP: | 235851 |
| Website: | danaher.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 1.87 |
| Quick Ratio: | 1.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.83 |
|---|---|
| Forward P/E Ratio: | 23.18 |
DHR Technical Analysis vs Fundamental Analysis
Buy
57
Danaher Corp. (DHR)
is a Buy
Is Danaher Corp. a Buy or a Sell?
-
Danaher Corp. stock is rated a BuyThe current Danaher Corp. [DHR] share price is $211.25. The Score for DHR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.